tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Charles Duncan, 336 are a BUY (88.65%), 38 are a HOLD (10.03%), 5 are a SELL (1.32%).
Analyst Charles Duncan works at CANTOR FITZGERALD with a stock forecast success ratio of 46.45% fulfilled within 271.45 days on average.
Charles Duncan’s has documented 760 price targets and ratings displayed on 55 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on ITCI, Intracellular Th at 24-Apr-2024.
Analyst best performing recommendations are on CLVS (CLOVIS ONCOLOGY).
The best stock recommendation documented was for RETA (REATA PHARMACEUTICALS) at 7/24/2023. The price target of $145 was fulfilled within 4 days with a profit of $35.33 (32.21%) receiving and performance score of 80.54.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
25
$8.41 (50.69%)
29
1 months ago
5/8 (62.5%)
$7.16 (40.13%)
26
Buy
30
$13.41 (80.83%)
40
1 months 12 days ago
16/19 (84.21%)
$10.44 (53.37%)
184
Buy
39
$22.41 (135.08%)
40
1 months 28 days ago
6/10 (60%)
$15.25 (64.21%)
94
Buy
33
$16.41 (98.92%)
33
1 months 28 days ago
8/19 (42.11%)
$9.25 (38.95%)
119
Buy
36
$19.41 (117.00%)
1 months 28 days ago
0/1 (0%)
$12.25 (51.58%)
Which stock is Charles Duncan is most bullish on?
Which stock is Charles Duncan is most reserved on?
What Year was the first public recommendation made by Charles Duncan?
